We are live on ! Find out more
PRC

Pearl River Capital Portfolio holdings

AUM $630M
1-Year Est. Return 17.08%
This Fund
S&P 500
This Quarter Est. Return
+20.49%
1 Year Est. Return
+17.08%
3 Year Est. Return
+20.29%
5 Year Est. Return
+57.93%
10 Year Est. Return
–
AUM
$201M
AUM Growth
+$149M
Cap. Flow
+$143M
Cap. Flow %
71%
Top 10 Hldgs %
12.72%
Holding
641
New
154
Increased
108
Reduced
3
Closed
376

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$2.86M
2
LHX icon
L3Harris
LHX
+$2.73M
3
SRE icon
Sempra
SRE
+$2.69M
4
CME icon
CME Group
CME
+$2.65M
5
GPN icon
Global Payments
GPN
+$2.53M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$760K
2
AEP icon
American Electric Power
AEP
+$752K
3
PG icon
Procter & Gamble
PG
+$749K
4
V icon
Visa
V
+$715K
5
EA icon
Electronic Arts
EA
+$650K

Sector Composition

Rank Sector Weight
1 Technology 21.17%
2 Financials 15.1%
3 Healthcare 13.84%
4 Consumer Discretionary 10.58%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AWI icon
301
Armstrong World Industries
AWI
$7.58B
– –
-283
Closed -$22K
AXSM icon
302
Axsome Therapeutics
AXSM
$10.9B
– –
-3,473
Closed -$204K
AZTA icon
303
Azenta
AZTA
$1.38B
– –
-205
Closed -$6K
BBY icon
304
Best Buy
BBY
$18B
– –
-251
Closed -$14K
BC icon
305
Brunswick
BC
$5.16B
– –
-913
Closed -$32K
BEN icon
306
Franklin Resources
BEN
$18.3B
– –
-8,440
Closed -$141K
BFAM icon
307
Bright Horizons
BFAM
$4.01B
– –
-11
Closed -$1K
BNY
308
Bank of New York Mellon
BNY
$106B
– –
-1,867
Closed -$63K
BKU icon
309
Bankunited
BKU
$3.4B
– –
-4,353
Closed -$81K
BMRN icon
310
BioMarin Pharmaceuticals
BMRN
$11.6B
– –
-1,527
Closed -$129K
BMY icon
311
Bristol-Myers Squibb
BMY
$134B
– –
-6,658
Closed -$371K
BOH icon
312
Bank of Hawaii
BOH
$3.16B
– –
-958
Closed -$53K
BPMC
313
DELISTED
Blueprint Medicines
BPMC
– –
-100
Closed -$6K
BRK.B icon
314
Berkshire Hathaway Class B
BRK.B
$1.11T
– –
-2,678
Closed -$490K
BRX icon
315
Brixmor Property Group
BRX
$9.68B
– –
-2,259
Closed -$21K
BWA icon
316
BorgWarner
BWA
$13B
– –
-3,104
Closed -$67K
C icon
317
Citigroup
C
$224B
– –
-1,518
Closed -$64K
CADE
318
DELISTED
Cadence Bank
CADE
– –
-1,017
Closed -$19K
CARG icon
319
CarGurus
CARG
$3.33B
– –
-2,541
Closed -$48K
CAT icon
320
Caterpillar
CAT
$382B
– –
-180
Closed -$21K
CATY icon
321
Cathay General Bancorp
CATY
$4.27B
– –
-67
Closed -$2K
CBRE icon
322
CBRE Group
CBRE
$43B
– –
-855
Closed -$32K
CBRL icon
323
Cracker Barrel
CBRL
$1.29B
– –
-100
Closed -$8K
CC icon
324
Chemours
CC
$2.57B
– –
-3,660
Closed -$32K
CCEP icon
325
Coca-Cola Europacific Partners
CCEP
$47.8B
– –
-79
Closed -$3K
11 12
13
14 15

Similar funds

SCM
Sahana Capital Management Greenwich, Connecticut $645M AUM 23.48% 1-Year Est. Return
IFAM
Institutional & Family Asset Management Fort Collins, Colorado $654M AUM 12.29% 1-Year Est. Return
GIM
Greylin Investment Management Orange, Virginia $598M AUM 18.59% 1-Year Est. Return
MCM
McKinley Capital Management Anchorage, Alaska $571M AUM 36.44% 1-Year Est. Return
AT
Arden Trust Wilmington, Delaware $716M AUM 17.63% 1-Year Est. Return
AC
Abbrea Capital Greenbrae, California $755M AUM 24.68% 1-Year Est. Return
PWS
Private Wealth Strategies New Albany, Ohio $498M AUM 17.23% 1-Year Est. Return
RVPG
Relative Value Partners Group $772M AUM 15.6% 1-Year Est. Return

Pearl River Capital's Q2 2020 Portfolio in Review

As of Q2 2020, Pearl River Capital held 641 positions worth $201M, up 288% from $51.8M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Pearl River Capital deployed $143M of net new capital in Q2 2020, opening 154 new positions and adding to 108 existing holdings. Its largest new stake was Biogen: 9,509 shares worth $2.54M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Applied Materials, an estimated $458K trimmed.

  • Pearl River Capital's largest Q2 2020 buy was Biogen: 9,509 shares worth $2.54M.
  • Pearl River Capital added most to L3Harris in Q2 2020, an estimated $2.73M increase.
  • Pearl River Capital's biggest Q2 2020 reduction was Applied Materials, cutting an estimated $458K.
  • Pearl River Capital fully exited Gilead Sciences in Q2 2020, selling an estimated $760K.
  • Pearl River Capital's ten largest holdings make up 13% of its $201M portfolio in Q2 2020.
  • Pearl River Capital opened 154 new positions and closed 376 in Q2 2020.
  • Pearl River Capital's portfolio value rose 288% quarter-over-quarter to $201M.

Based on Pearl River Capital's 13F filing for Q2 2020, filed 10 Aug 2020.